To evaluate the efficacy and safety of single combined (long- or short-acting beta₂ agonist plus an inhaled corticosteroid (ICS)) inhaler only used as needed in people with mild asthma.
This is a protocol.
To evaluate the efficacy and safety of single combined (long- or short-acting beta₂ agonist plus an inhaled corticosteroid (ICS)) inhaler only used as needed in people with mild asthma.
This is a protocol.